<div id="readability-page-1"><div>Trimarchi Thomas President of Bridgebio Pharma Inc [BBIO] filed a Form 4 on December 16, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:<div><table><tbody><tr><th>Date</th><th>Transaction</th><th>Shares</th><th>Price</th><th>Value</th></tr><tr><td>12/12/25</td><td>Exercise</td><td>25,000</td><td>$0.00</td><td>N/A</td></tr><tr><td>12/12/25</td><td>Surrender(1)</td><td>13,826</td><td>$75.15</td><td>$1,039,024</td></tr></tbody></table></div>Ending Holdings: 369,004 - Direct<ul><li>(1)</li><li>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</li></ul>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data. </div></div>

BBIO

Trimarchi Thomas, President of Bridgebio Pharma Inc [BBIO], filed a Form 4 on December 16, 2025, disclosing changes in ownership. He exercised 25,000 shares and surrendered 13,826 shares at $75.15 each to cover option exercise costs and tax liabilities. His ending holdings are 369,004 shares directly.

Pres Trimarchi Acquires 11,174 Of Bridgebio Pharma Inc [BBIO]